Wedbush Reiterates Outperform on Imax, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Alicia Reese reiterates an Outperform rating on Imax (NYSE:IMAX) and maintains a $22 price target.
March 04, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wedbush analyst Alicia Reese reiterates an Outperform rating on Imax and maintains a $22 price target.
The reaffirmation of an Outperform rating and a $22 price target by a Wedbush analyst suggests a positive outlook for Imax's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100